Key result
High AGEF score linked to ~208% higher 90-day mortality in cardiogenic shock.
Why the study?
The AGEF score correlates with mortality in STEMI, but its relationship with mortality in cardiogenic shock remains unknown.
Does the AGEF score predict all-cause 90-day mortality in patients with cardiogenic shock?
Observational (n=168)
Yes
Does the AGEF score predict all-cause 90-day mortality in patients with cardiogenic shock?
The AGEF score demonstrates moderate discrimination ability as a prognostic indicator for 90-day all-cause mortality in patients with cardiogenic shock.
Answers are grounded in this paper and cite their sources.
May aid prognostication in cardiogenic shock; hypothesis-generating pending prospective validation.
AIMS: Age, estimated glomerular filtration rate and ejection fraction (AGEF) score correlates with mortality in patients with ST-elevation myocardial infarction, yet its relationship with cardiogenic shock mortality remains unknown. OBJECTIVES: This research aims to explore the correlation between AGEF and the probability of all-cause 90-day mortality in patients with cardiogenic shock. METHODS: Our study included 168 cardiogenic shock patients from a multicenter, prospective, observational study. The Cox regression model, subgroup analyses, Kaplan-Meier survival curves, and restricted cubic spline analysis were applied to assess the relationship between AGEF and 90-day mortality. Receiver-operating characteristic curve analysis was performed to evaluate the predictive accuracy of AGEF for 90-day mortality. RESULTS: High AGEF scores correlated with significantly higher mortality (56.1 vs. 19.7%, P < 0.05). AGEF was significantly associated with 90-day mortality [hazard ratio: 1.33, per 1-point increase, 95% confidence interval (95% CI) 1.03-1.70, P < 0.001; hazard ratio: 1.65, per 1 standard deviation increase, 95% CI 1.27-2.14, P < 0.001]. The high AGEF group had a two-fold higher risk of 90-day mortality (hazard ratio: 3.08, 95% CI 1.48-6.41, P < 0.001). Kaplan-Meier curve analysis revealed a higher probability of 90-day death in the group with higher AGEF scores. The restricted cubic spline analysis also suggested a linear relationship between AGEF and 90-day mortality. The area under the receiver-operating characteristic curve for the AGEF was 0.71 (95% CI 0.633-0.787), indicating moderate discrimination ability. CONCLUSION: AGEF is significantly associated with all-cause 90-day mortality in patients experiencing cardiogenic shock, indicating its potential as a prognostic indicator in this patient population.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2025) conducted an observational in cardiogenic shock (n=168). High AGEF score vs. Low AGEF score was evaluated on all-cause 90-day mortality (HR 3.08, 95% CI 1.48-6.41, p=<0.001). A high AGEF score was associated with a higher risk of all-cause 90-day mortality compared to a low score in patients with cardiogenic shock.
Synapse has enriched 10 related papers. Consider them for comparative context: